TD Asset Management Inc Lowers Stake in HealthEquity, Inc. $HQY

TD Asset Management Inc reduced its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 15.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,642 shares of the company’s stock after selling 3,664 shares during the quarter. TD Asset Management Inc’s holdings in HealthEquity were worth $2,058,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of HQY. Invesco Ltd. boosted its stake in shares of HealthEquity by 50.6% during the 1st quarter. Invesco Ltd. now owns 2,446,198 shares of the company’s stock worth $216,171,000 after acquiring an additional 821,425 shares in the last quarter. Nuveen LLC purchased a new stake in shares of HealthEquity during the 1st quarter worth about $53,076,000. Price T Rowe Associates Inc. MD boosted its stake in shares of HealthEquity by 995.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock worth $56,500,000 after acquiring an additional 580,988 shares in the last quarter. Westfield Capital Management Co. LP purchased a new stake in shares of HealthEquity during the 1st quarter worth about $49,787,000. Finally, Ameriprise Financial Inc. boosted its stake in shares of HealthEquity by 148.1% during the 1st quarter. Ameriprise Financial Inc. now owns 669,939 shares of the company’s stock worth $59,203,000 after acquiring an additional 399,897 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on HQY. KeyCorp decreased their price target on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 8th. Royal Bank Of Canada raised their price target on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, September 3rd. Raymond James Financial reaffirmed a “strong-buy” rating and issued a $120.00 price target (up from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Jefferies Financial Group raised their price target on shares of HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research note on Wednesday, September 3rd. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $125.00 price target on shares of HealthEquity in a research note on Friday, August 29th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $121.31.

HealthEquity Stock Up 3.2%

HQY stock opened at $96.00 on Wednesday. The company has a market cap of $8.27 billion, a price-to-earnings ratio of 58.18, a PEG ratio of 1.34 and a beta of 0.47. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 12 month low of $74.07 and a 12 month high of $116.65. The firm has a 50-day moving average of $91.77 and a two-hundred day moving average of $94.21.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, meeting analysts’ consensus estimates of $0.92. The company had revenue of $325.80 million during the quarter, compared to the consensus estimate of $320.68 million. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. As a group, analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 6,000 shares of the stock in a transaction dated Friday, September 19th. The shares were sold at an average price of $94.11, for a total value of $564,660.00. Following the completion of the sale, the executive vice president owned 79,456 shares in the company, valued at approximately $7,477,604.16. This represents a 7.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael Henry Fiore sold 1,781 shares of the stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by corporate insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.